POC Advantage Ohmx offers a portable, low-cost, comprehensive point-of-care platform capable of quantitative analysis across DNA, proteins, and small molecules from minimal samples, presenting a compelling value proposition for clinics, urgent care, and community labs seeking rapid diagnostics at the bedside.

Chronic & Acute Target customers include healthcare providers managing chronic and acute diseases who need screening, diagnosis, and monitoring at the point of care, enabling recurring device usage and consumable sales through ongoing patient management workflows.

Cost Efficiency With a sub-$1M revenue base and a recent funding round, emphasize total cost of ownership reductions for customers via faster decision-making, reduced lab outsourcing, and preventive care initiatives that may lower overall healthcare costs.

Strategic Partnerships Position Ohmx as a platform play that could integrate with existing medical devices or lab networks; align with distributors and regional healthcare providers to accelerate adoption in ambulatory settings and small clinics lacking full-scale labs.

Market Readiness Leverage the novelty of a universal POC quantitative platform to differentiate in the diagnostics space, focusing on early adopters in clinics and specialty centers, while highlighting scalable funding and deployment trajectories to support rapid expansion.